Horizon Therapeutics Public Limited (NASDAQ:HZNP) Expected to Earn Q4 2023 Earnings of $1.88 Per Share

Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) – Research analysts at HC Wainwright raised their Q4 2023 earnings per share (EPS) estimates for shares of Horizon Therapeutics Public in a note issued to investors on Wednesday, August 9th. HC Wainwright analyst D. Tsao now expects that the biopharmaceutical company will earn $1.88 per share […]

Related Keywords

,Horizon Therapeutics Public Limited Company ,Wahed Invest ,Horizon Therapeutics Public Limited ,Kiwi Wealth Investments Limited Partnership ,Gamco Investors ,Free Report ,Horizon Therapeutics Public ,Therapeutics Public ,Get Free Report ,Wealth Investments Limited Partnership ,Therapeutics Public Limited Company ,Horizon Therapeutics Public Daily ,Nasdaq Hznp ,Hznp ,Medical ,44047t10 ,Earnings Estimates ,Hc Wainwright ,